Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-06FDA Approved: TICAGRELOR — Original Application (Lifestar Pharma LLC)
The FDA approved Lifestar Pharma LLC's original ANDA for ticagrelor, a P2Y12 receptor inhibitor used to reduce thrombotic cardiovascular eve…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Transcultural Digital Solutions in Phase III Cardiac Rehabilitation [NA]
Clinical trial update for a Phase III cardiac rehabilitation study using transcultural digital solutions; the trial is not yet recruiting.
-
EMA approval · 2026-02-05EMA Authorised: Clopidogrel Zentiva (previously Clopidogrel Winthrop) (clopidogrel) — Zentiva k.s.
The European Medicines Agency authorised Zentiva’s generic clopidogrel product for prevention of stroke, myocardial infarction, acute corona…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Diagnostic Accuracy of ECG-less Gated Cardiac CT in Resuscitated Cardiac Arrest Survivors Without ST Elevation Myocardial Infarction [NA]
A study evaluating the diagnostic accuracy of ECG-less gated cardiac CT in resuscitated cardiac arrest survivors without ST-elevation MI is …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack [Phase 2]
A Phase 2 trial evaluating BI 765845 in people who have had a myocardial infarction has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: The Effect of HIIT, MICT in Patients With Myocardial Infarction [NA]
A completed clinical trial evaluating high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) in patients …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction [Phase 3]
A Phase 3 clinical trial is evaluating whether fexofenadine hydrochloride can affect prognosis after acute myocardial infarction and is curr…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation
This document provides an update on a trial evaluating evolocumab in patients with multivessel coronary artery disease after acute myocardia…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock [Phase 1]
Phase 1 trial update evaluating the safety and efficacy of FAP iCDC in patients with acute myocardial infarction complicated by cardiogenic …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Cohort of STEMI Patients 2 [NA]
A Cohort of STEMI Patients 2 is currently recruiting in a study sponsored by Hospices Civils de Lyon, focusing on myocardial infarction.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
Clinical trial update for an acute myocardial infarction prognostic and therapeutic evaluation; currently recruiting.
-
EMA approval · 2026-01-29EMA Authorised: Arixtra (fondaparinux sodium) — Viatris Healthcare Limited
The EMA authorised Arixtra (fondaparinux sodium) by Viatris Healthcare Limited for thromboembolic conditions including venous thrombosis, pu…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial [NA]
The VULNERABLE trial is currently recruiting to assess treatment of functionally non-significant vulnerable plaques in patients with multive…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO) [NA]
A completed clinical trial evaluating the Shockwave C2+ 2Hz Coronary IVL Catheter in calcified coronary arteries (Disrupt CAD DUO); results …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Very Early PCSK9 Inhibition for Acute Myocardial Infarction [NA]
A clinical trial update indicates a very early PCSK9 inhibition strategy for patients with acute myocardial infarction is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction [Phase 4]
Update on a Phase 4 clinical trial evaluating early PCSK9 inhibitor treatment after acute myocardial infarction; the study is currently recr…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Focused Orticumab Research for Treating Inflammation in Coronary Arteries [Phase 2]
Phase 2 clinical trial update for Orticumab targeting inflammation in coronary arteries; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: SpinChip Hs-cTnI Clinical Diagnostic Performance
The update reports results from a completed study evaluating the diagnostic performance of SpinChip Hs-cTnI for acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Acute Myocardial Infarction Clinical Intelligent Decision Support System
This entry updates a trial evaluating an acute myocardial infarction clinical intelligent decision support system powered by large language …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: SpinChip Hs-cTnI Determination of the 99th Percentile URL
Clinical trial update noting the completion of SpinChip Diagnostics ASA's study evaluating the SpinChip Hs-cTnI assay for determining the 99…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional. [NA]
The clinical trial update indicates completion of a Phase 3 study evaluating a therapeutic consolidation educational program for myocardial …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome [Phase 4]
Phase 4 clinical trial evaluating the VerifyNow platelet function testing system to optimize platelet inhibition in acute coronary syndrome …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: The Application of T1 Mapping in Real-World
A real-world study evaluating the use of T1 mapping in patients with myocardial infarction, hypertrophic cardiomyopathy, dilated cardiomyopa…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Multi-Ethnic Study of Atherosclerosis (MESA)
This clinical trial update shows the Multi-Ethnic Study of Atherosclerosis (MESA) is currently active but not recruiting participants, with …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock
ClinicalTrials.gov entry for an ongoing study evaluating prognosis in patients with mixed cardiogenic and vasoplegic shock. The study includ…